Investigation reveals that L-PGDS facilitates rapid conversion of Prostaglandin D2, suggesting therapeutic potential for modulating its effects in the arachnoid membrane.
Understanding the metabolic pathways and kinetics of prostaglandins is essential for elucidating their biological functions and therapeutic potential. Prostaglandin D₂ (PGD₂), a somnogen in the brain, undergoes nonenzymatic conversion into J-series prostaglandins, including 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂ (15d-PGJ₂). PGD₂ is possibly transported by lipocalin-type prostaglandin D synthase (L-PGDS), which may also influence its metabolism. However, the kinetics of PGD₂ metabolism, particularly in the context of the PGD₂-L-PGDS complex, remains poorly understood. In this study, we investigated the effects of L-PGDS on the dehydration reaction of PGD₂ in an aqueous buffer using real-time NMR spectroscopy, complemented by UV-visible absorption spectroscopy. In the absence of L-PGDS, 15d-PGJ₂ was formed over several tens of hours via the transient accumulation of prostaglandin J₂ and 15-deoxy-Δ¹²,¹⁴-prostaglandin D₂ as intermediates. In contrast, the PGD₂-L-PGDS complex converted to a L-PGDS-15d-PGJ₂ complex, without exhibiting detectable reaction intermediates or byproducts, at a time scale of 3 h. We also determined the crystal structure of the L-PGDS-15d-PGJ₂ complex, demonstrating that the covalent bond is formed between Cys65 of L-PGDS and the carbon atom at the C9 position of 15d-PGJ₂. These results, combined with the fact that L-PGDS is present in excess relative to PGD₂ and 15d-PGJ₂ in the arachnoid membrane, suggest that most PGD₂ exists in the L-PGDS-bound form and that 15d-PGJ₂ generated through dehydration is rapidly and effectively sequestered by L-PGDS. Thus, L-PGDS may function as a scavenger for 15d-PGJ₂, mitigating its potential deleterious effects in the arachnoid membrane. This real-time NMR-based approach provides a useful platform for studying the metabolism behavior of other prostaglandins under physiologically relevant conditions.
No takes yet. Share an insight, caveat, or question.
Ohta et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: